Zealand Pharma A/S, a biotechnology company, has appointed Steven Johnson as Chief Development Officer. Johnson will join the executive team to lead regulatory and development strategies. His appointment, alongside Chief Medical Officer, David Kendall and recently appointed Chief Scientific Officer, Utpal Singh further strengthens the company’s strategy to lead the field in innovation in the management of obesity and other related conditions. “Steven brings a unique 360-degree perspective ...